The effectiveness and safety of Chinese patent medicines plus calcium dobesilate for the treatment of diabetic retinopathy: A network meta-analysis
Objectives: Chinese patent medicines (CPMs) are commonly prescribed by clinicians in China as adjuvant therapy for diabetic retinopathy (DR). The study of network meta-analysis (NMA) aims to compare the effectiveness and safety of three CPMs plus calcium dobesilate (CD) for DR, and to explore optima...
Main Authors: | Xiyuan Deng, Ya Mo, Xiuying Zhu, Shumin Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024005644 |
Similar Items
-
Effect of calcium dobesilate combined with panretinal photocoagulation on severe non-proliferative diabetic retinopathy patients
by: Gao-Chun Li, et al.
Published: (2018-04-01) -
Effect of calcium dobesilate on vitreous hemorrhage in patients with PDR after pan retinal photocoagulation
by: Yan-Xia Lu, et al.
Published: (2018-07-01) -
The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials
by: Ziqiang Liu, et al.
Published: (2023-04-01) -
Effects of calcium dobesilate in the treatment of non-proliferative diabetic retinopathy after panretinal laser photocoagulation
by: Le Yang, et al.
Published: (2018-02-01) -
Effect of fundus retinal argon laser photocoagulation combined with calcium dobesilate in the treatment of diabetic retinopathy
by: Jing Liu, et al.
Published: (2021-01-01)